Point of Care (PoC) Diagnostic Devices Market: By Application (Glucose Testing, Cholesterol Testing and Others); By End User (Clinics, Hospitals and Others); By Technology (Molecular Diagnostics, Non-invasive Technology and Others) & By Geography – Forecast (2015 – 2020)

“Point-of-Care (POC) testing is an immediate testing service performed within close proximity of the patient. Global POC diagnostic devices market has been classified into three segments such as by application, by end user and by technology, providing exhaustive value analysis for the year 2014 and forecast to 2020. This market has been growing at a very rapid pace for the last few years and is projected to grow with a healthy CAGR of 10.65% through 2020 to generate $34 billion.

The North American market followed by Europe account for the largest share in the global POC diagnostic devices market in 2014. It is estimated to grow at a CAGR of 10.01% from 2015 to 2020. Good clinical and economic outcome, increase in aging population and obesity are main factors that are steering the market. The U.S. constitutes a major share in healthcare industry. Majority of POC devices are applicable for chronic diseases and in North America, where nearly 1 in 2 adults live with at least one chronic disease, according to the Centers for Disease Control and Prevention (CDC). The APAC region is poised to grow with the highest CAGR of 11.95% during the forecast period, owing to APAC’s rapidly aging population and higher obesity rates when compared to North America, Europe and rest of the world.

Regular blood glucose monitoring is mandatory for diabetes patients and the majority of POC diabetic testing devices are utilized by them. Patient self-testing dominated the POC diabetic testing devices market in 2014 and also is projected to grow with the highest CAGR through 2020. According to World Health Organization (WHO), the percentage of diabetic patients in the world population was 2.8% in 2000 and it is estimated grow up to 4.4% by 2030. Keeping these factors in mind, the companies which are manufacturing POC devices at least have blood glucose monitoring systems in their product portfolio. Roche point-of-care, Alere Inc., Siemens Health, Bayer Diabetes Care and Abbott point-of-care are the major market share holders for the POC blood glucose analyzers.”

“1. Global POC Diagnostic Devices – Market Overview
   1.1. What is POC testing?
   1.2. Advantages of POC testing
   1.3. Disadvantages of POC testing
   1.4. Market Overview
   1.5. Research Objective
   1.6. Research methodology
2. Executive Summary
3. Global POC Diagnostic Devices Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. Top 5 Financials Analysis
4. Global POC Diagnostic Devices – Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Global POC Diagnostic Devices Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product/Market Life Cycle Analysis
6. Global POC Diagnostic Devices Market – By Application
   6.1. Diabetic testing
   6.2. Infectious Diseases
   6.3. Coagulation
   6.4. Urinalysis
   6.5. Haematology
   6.6. Cholesterol Testing
   6.7. Drug of Abuse Testing
   6.8. Cardiac Markers
   6.9. Blood Gas/Electrolytes
   6.10. Tumor/ Cancer Markers
   6.11. Fertility
   6.12. Others
7. Global POC Diagnostic Devices Market – By End user  
   7.1. Patient Self-Testing
   7.2. Clinics
   7.3. Hospitals
   7.4. Laboratories
8. Global POC Diagnostic Devices Market – By Technology
   8.1. Miniaturization and Microfluidics Technology
   8.2. Molecular Diagnostics 
   8.3. Non-Invasive Technology  
9. Global POC Diagnostic Devices Market – By Geography
   9.1. Introduction 
   9.2. North America
      9.2.1. USA
      9.2.2. Canada 
      9.2.3. Mexico
   9.3. Europe
      9.3.1. France
      9.3.2. Germany
      9.3.3. Italy
      9.3.4. UK
      9.3.5. Spain
      9.3.6. Others
   9.4. APAC
      9.4.1. China
      9.4.2. India
      9.4.3. Japan
      9.4.4. Others
   9.5. ROW
      9.5.1. Brazil
      9.5.2. Russia
      9.5.3. Saudi Arabia
      9.5.4. South Africa
      9.5.5. Others
10. Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs and Partnerships
11. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)
   11.1. Roche Diagnostics
   11.2. Abaxis
   11.3. Abbott POC
   11.4. Alere Inc.
   11.5. Beckman Coulter
   11.6. Beckton & Dickinson
   11.7. Bayer Diabetes Care
   11.8. Hemocue AB
   11.9. International Technidyne Corporation
   11.10. LifeScan Inc.
   11.11. Nipro Diagnostics
   11.12. Orasure Technologies
   11.13. PointCare Technologies
   11.14. Siemens HealthCare Diagnostics
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies””
12. Appendix
   12.1. Abbreviation
   12.2. Sources
   12.3. Bibliography
   12.4. Disclaimer
PLEASE SELECT LICENCE
 Single User Licence:
US $4250
 Corporate User Licence: 
US $6250
PROCURE NOW
Request Sample Brochure
Inquiry Before Buying
“
“11.1. Roche Diagnostics
   11.2. Abaxis
   11.3. Abbott POC
   11.4. Alere Inc.
   11.5. Beckman Coulter
   11.6. Beckton & Dickinson
   11.7. Bayer Diabetes Care
   11.8. Hemocue AB
   11.9. International Technidyne Corporation
   11.10. LifeScan Inc.
   11.11. Nipro Diagnostics
   11.12. Orasure Technologies
   11.13. PointCare Technologies
   11.14. Siemens HealthCare Diagnostics”